KEQU
Kewaunee ScientificBNasdaq / Health Care Equipment & Services
Last Price
At close
2026-06-02
Current thesis
KEQU still posted year-over-year Q3 sales growth, international profit strength, and positive year-to-date earnings, so a clean Q4 showing could re-rate the shares if backlog converts better than feared and Nu Aire integration matures [#8-K-2026-03-11].
Posture
Constructive
Lead driver
Momentum
What changed
Momentum remains the lead driver in the composite.
What can break
Cash fell versus fiscal year-end and interest expense increased year to date following the Nu Aire transaction.
Momentum
75
Value
71
Sentiment
35
Setup hits (3d)
0 · Net Neutral
AI TargetsBase $35.00 · Bull $42.00 · Bear $27.00
Data freshness
Prices
As of 2026-06-02
Fundamentals
As of 2026-06-01 • Vendor: Data Vendor v1
Scores
As of 2026-06-02 • Model: HYBRID_IC_RP
AI Memo
As of 2026-04-15 • Model: RankAlpha Sentiment Codex
Investment thesisAs of 2026-06-02
Investment thesis
As of 2026-06-02
Supporting evidence
What
Grade B · Constructive
Confidence Medium · Net Neutral
Why
Momentum75 · Δ7d -
Value71 · Δ7d +0.0
Sentiment35 · Δ7d -
So what
Strength-led posture (Net Neutral). Favor watchlist adds and disciplined entries.
Lead driver: Momentum · See technicals
Momentum
75
34% active weight
Current posture
7d trendTrend unavailable
Trend unavailable
Δ7d
-
Δ21d
-
Value
71
32% active weight
Current posture
7d trendFlat
Δ7d
+0.0
Δ21d
-0.4
Sentiment
35
33% active weight
Current posture
7d trendTrend unavailable
Trend unavailable
Δ7d
-
Δ21d
-
Why this grade
Composite grade B. Momentum 74.8 / Value 71.2 / Sentiment 35.2
Fundamentals (TTM)As of 2026-06-01
Fundamentals (TTM)
As of 2026-06-01
Market Cap
$116.81M
Beta
0.56
Shares Out
2.87M
P/E (TTM)
9.8
P/S (TTM)
0.39
P/FCF (TTM)
5.88
Rev YoY
+46.8%
EPS YoY
-19.2%
Gross Margin
+29.1%
Op Margin
+6.9%
Net Debt
$50.56M
Current Ratio
2.32
As of 2026-06-02 • Updated nightlySource: Internal modelMethodology